Novavax

Novavax

35 bookmarks
Custom sorting
2024-Q2-Earnings-Presentation.pdf
2024-Q2-Earnings-Presentation.pdf

August, 2024

Excellent broad cross neutralization to variants with the upcoming JN.1 Novavax COVID vaccine, including some of the best responses to variants that are likely to be dominant this late fall and early winter

·novavax.widen.net·
2024-Q2-Earnings-Presentation.pdf
Today, we granted emergency use authorization for an updated Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death.
Today, we granted emergency use authorization for an updated Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death.
“Today, we granted emergency use authorization for an updated Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death.”
·x.com·
Today, we granted emergency use authorization for an updated Novavax COVID-19 vaccine that more closely targets currently circulating variants to provide better protection against serious consequences of COVID-19, including hospitalization and death.
Flew in from Asia today to learn the exciting news that Novavax's JN.1 booster has been approved!
Flew in from Asia today to learn the exciting news that Novavax's JN.1 booster has been approved!

excellent explanation thread of differences between Novavax and MRNA vaccines.

“Novavax, likely because its stimulation method is slow and steady, instead of creating a hot and heavy pseudoinfection in your muscles like RNA, does not induce the IgG4 isotype switch. It instead generates more IgG3, with the most Fc effector function.”

·x.com·
Flew in from Asia today to learn the exciting news that Novavax's JN.1 booster has been approved!